Pediatrix Medical
355 hedge funds and large institutions have $6.94B invested in Pediatrix Medical in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 129 increasing their positions, 152 reducing their positions, and 24 closing their positions.
25% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 24
0.85% more ownership
Funds ownership: 99.41% → 100.27% (+0.85%)
1% more funds holding
Funds holding: 353 → 355 (+2)
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
3% less capital invested
Capital invested by funds: $7.17B → $6.94B (-$234M)
15% less repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 152
33% less call options, than puts
Call options by funds: $637K | Put options by funds: $949K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$52.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.3M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.2M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$11.2M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$116M |
| 2 |
Millennium Management
New York
|
-$31.4M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$25.7M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$23.5M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$19.4M |
MD Hedge Fund Activity: Q2 2015 in Review
355 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2015, worth a combined $6.94B — down 3.3% from $7.17B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new MD positions and 24 closed out — a net gain of 6 holders — while 129 added to existing stakes and 152 trimmed.
The largest buyer was Boston Partners, opening a new position worth an estimated $52.2M. The largest seller was Bank of New York Mellon, cutting an estimated $116M.
- 355 institutional investors held Pediatrix Medical (MD) as of Q2 2015, up from 353 in Q1 2015.
- Funds reported $6.94B of Pediatrix Medical stock for Q2 2015, down 3.3% quarter-over-quarter.
- 30 funds opened new Pediatrix Medical positions in Q2 2015 and 24 closed out, a net change of +6 holders.
- The largest Pediatrix Medical buyer in Q2 2015 was Boston Partners, an estimated $52.2M added.
- The largest Pediatrix Medical seller in Q2 2015 was Bank of New York Mellon, an estimated $116M sold.
Based on aggregated 13F filings for Q2 2015.